Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$KAVL E-Cigs 30.6% Growth Projected Thru 2030: $BTAFF $PM $MO $IMBBF
https://www.benzinga.com/pressreleases/23/02/ab30915803/capitalgainsreport-e-cigarettes-30-6-growth-projected-through-2030-kavl-btaff-pm-mo-imbbf
you guys just like losing money don't you?
Me too at .77 +/-......Great buy here on any bounce
Just jumped back into KAVL at .71 on the double bottom... Just a chart play for now.
Nothing new, same old song
#BreakingNews - Kaival Reports 2022 Financials and 2023 Outlook – NASDAQ: $KAVL NYSE: $PM
GRANT, Fla., Jan. 30, 2023 - Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) the exclusive U.S. distributor of the BIDI ® Stick electronic nicotine delivery system, today announced its financial results for the fiscal 2022 fourth quarter and full year ended October 31, 2022, and looks forward to 2023 w/Philip Morris (NYSE: PM) International Distribution Agreement in full swing and Favorable Decision by Appellate Court Allowing for Renewed Non-Tobacco Flavored BIDI® Sticks US Sales
https://finance.yahoo.com/news/kaival-brands-reports-fiscal-fourth-131500936.html
Nice I'm surprised not a better reaction
Kaival Brands' (NASDAQ: $KAVL) Strengthens in U.S. w/ District Court Decision And Globally w/Philip Morris (NYSE: $PM) Partnership https://topnewsguide.com/2022/12/28/kaival-brands-nasdaq-kavl-strengthens-in-u-s-w-district-court-decision-and-globally-w-philip-morris-nyse-pm-partnership/
$KAVL DD
BIDI Vapor](https://1drv.ms/u/s!ArAyaAmAjM5c3xGSzdVQ9oSZZEzE?e=VNxKRS) - Product focused sales deck
[Nielsen report](https://1drv.ms/u/s!ArAyaAmAjM5c3xzHPkstcZS8FfY9?e=GcwiP3) – specifically pages 12-14
[PMI Investor information](https://1drv.ms/u/s!ArAyaAmAjM5c3xATJAN6f8hahKF4?e=t8hst9) – page 56 includes data on launched markets
[Investor presentation](https://1drv.ms/u/s!ArAyaAmAjM5c3x-qX6N2SZcmHkUQ?e=FApAYD)
Kaival Brands Expertly Navigates ENDS Market Restrictions; Looks to Capitalize on Now-Sparse Competitive Landscape (NASDAQ: KAVL)
https://www.marketwatch.com/press-release/kaival-brands-expertly-navigates-ends-market-restrictions-looks-to-capitalize-on-now-sparse-competitive-landscape-nasdaq-kavl-2022-12-08
$KAVL Kaival Marketing Services Hires Former Swisher International VP of Sales
https://finance.yahoo.com/news/kaival-marketing-services-hires-former-131500488.html
DELIST coming for this POS and YES, the CEO is a POS LIAR!!!!!!!!!!!!!!!!!!!!!
They become a subsidiary of PM, but not until the ceo finishes unloading his shares so the insiders can all have a piece of the action...
In my opinion I think they become a major player in the electronic nicotine segment or they will get bought out before it happens.
CEO IS A LIAR IS THE REASON
Sure bro. Just toss some moar money into the fire
I hope your right but doesn’t look like anything moving in this market
Exactly what?
What the end of Kavl lol
So Kavl went up $600,000 in revenue but it costs the company a million dollars to do it and I’m suppose to get excited. The CEO also has stated numerous times that Kavl is either number one or number two in the USA market yet they only have 3.8 million in revenue. Something is not right here.
Kaival Brands Innovations Group Inc (NASDAQ: $KAVL ) Reports Higher Revenue in Q3
https://thestreetreports.com/kaival-brands-innovations-group-inc-nasdaqkavl-reports-higher-revenue-in-q3/
Kaival Brands Innovations Group Inc (NASDAQ:KAVL) has made considerable progress over the course of the year so far and earlier this week on September 12 it was in the news after it announced its financial results for the fiscal third quarter. It may be a good idea for investors to consider taking a closer look at it in order to have a better idea about the situation at the company.
Market Stats
On Wednesday, KAVL stock fell 1% to $1.18 with 100K shares, compared to its average volume of 1.73 million shares. The stock moved within a range of $1.1600 – 1.2100 after opening trading at $1.19.
On the financial performance front, the company managed to bring in revenues of $3.8 million for the quarter and that was a significant improvement on the $3.2 million in revenues that it had earned in the prior year period. This topped analysts’ estimates by $0.35 million.
The gross profits for the third quarter stood at $442100 and that was again an improvement on the $84300 that it had generated in gross profits in the prior year period. On the other hand, the operating expenses actually went up to $4.3 million from $3.3 million in the prior year period. Net losses suffered by Kaival Brands was $3.9 million and that actually widened from the $3.4 million net loss in the prior year period.
There were some significant milestones that had been achieved by the company during the third quarter. The most important one was perhaps the international licensing agreement that was agreed by Kaival Brands International LLC, the company’s fully owned subsidiary with Phillip Morris Products SA. Phillip Morris Products SA is a fully owned affiliate of the tobacco behemoth Phillip Morris International Inc.
However, that is not all. Another major highlight from the third quarter for Kaival Brands was the launch of VEEBA, a customized branded product with a self-contained e-vapor. The product is going to be sold in Canada and the royalties that are going to accrue to Kaival Brands are in line with the international licensing agreement with Philip Morris.
Traders Corner
KAVL stock is trading below the 20-Day and 50-Day Moving averages of $1.20 and $1.21 respectively. Moreover, the stock is trading below the 200-Day moving average of $1.31.
Lll wrong board
You don't say
Good day here.
I'm holding $9-$10 as well
Thx Randy, I don't really have a big portfolio of Kavl but I ve been holding over 6 months and I don't have any intention to sell it less than $10...since Big MO does all the distribution and marketing on behalf of Kaival, means very big to me...it could be a take over sooner or later ...we have the market leader it's own category
Let's se what brings coming days....
I was just on the NASDAQ page looking at the information about KAVL. ..
Check out the Institutional holders:
https://www.nasdaq.com/market-activity/stocks/kavl/institutional-holdings
Total Institutional Shares :
Holders: 21
Number of shares: 1,220,351
Vanguard holds over 750,000 shares .... so I'm guessing they were not included in the shares bought and sold today.
Following big money seems like a pretty good idea.
Yeah, I think there are too many bright spots on the horizon to hold KAVL down much longer.
1. The Material details of the Phillip Morris worldwide distribution agreement
2. The 10Q is scheduled to come out in a little over two weeks. While it probably won't be stellar, they should be able to give some pretty reliable estimates for the current quarter and fiscal year.
3. Very few people own shares for less money than the current price. If public confidence grows toward the company's long-term success investors will be patient to bide their time. One would think KAVL would be impervious to inflation and recession. There are some things that people just won't live without.
Today the stock traded almost twice the outstanding shares today...AND ALMOST FOUR TIMES THE PUBLIC FLOAT.
With the volume of over 54 Million shares, the Volume Weighted Average Price was $1.57... so it seems to me that very few people own shares for less than the current price. AND... I would think the shorters were seeing that writing on the wall as well and will have to cover sooner and later.
it's probably a MM pump & dump before the stock buyout by PM
Shorties are working hard to bring it down...but I think it will bounce back and see it over $3 by Monday
would be nice if they were
The FDA is garbage. They make all the companies submit paperwork. Charge multi million dollars, and than they say oh wait we don’t have the resources to review ANY submissions and reject everyone… welcome to the Democratic Party. Pure bull kaka. Imagine the balls to say we don’t have the resources now…
Good news, but still cloud over this because, all this does is require them to take another look, they still can reissue same MDOs at the end of it all. Not sure if any other companies have been cleared for flavored products.. Maybe Kaival will be the trend setter.
hopefully itll hold this time
Already traded 6.8 million pre-market…
Up 40 cents!!
Bidi Vapor Wins Merits Case Against FDA; Kaival Brands Anticipates Revenue Growth From Decision
August 25 2022 - 08:30AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook
Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) (“Kaival Brands,” the “Company,” or “we”), the exclusive U.S. distributor of products manufactured by Bidi Vapor, LLC (“Bidi Vapor”), including the BIDI® Stick self-contained electronic nicotine delivery system (“ENDS”), which is intended exclusively for legal-age nicotine users, announced that the U.S. Court of Appeals for the Eleventh (11th) Circuit has ruled 2-1 in Bidi Vapor’s favor, granting its petition for review, and setting aside and remanding as arbitrary and capricious the U.S. Food and Drug Administration’s (“FDA”) order denying the Premarket Tobacco Product Applications (“PMTA”) for the non-tobacco flavored BIDI® Sticks.
Failure by FDA to Consider Marketing Plans and Sales-Access-Restrictions
On August 23, 2022, the 11th Circuit held that FDA’s Marketing Denial Order (“MDO”) issued against Bidi Vapor’s non-tobacco flavored ENDS devices was “arbitrary and capricious,” primarily because FDA failed to consider the relevant marketing and sales-access-restrictions plans included in Bidi Vapor’s comprehensive PMTAs.
“Distribution in the ENDS market has been challenging to say the least, especially regarding compliance with FDA policies and procedures. As the exclusive U.S. distributor of Bidi Vapor’s products, this is a significant event for us and our downstream partners, as many awaited the decision before expanding distribution, and paves the way for potential revenue growth for our company,” said Eric Mosser, President and Chief Operating Officer of Kaival Brands.
“But more than that, we are glad the appellate court recognized the potential importance and direct effects that an adult-focused marketing plan and strict sales and access restrictions may have on addressing the youth access problem,” continued Mr. Mosser. “We strongly believe that the appeal to and illegal usage by youth can be significantly reduced, not by banning flavors which are necessary for adult smokers seeking non-combustible alternatives to cigarettes, but with responsible marketing, adult-oriented packaging, restrictive online access, and enforcement of the current laws and regulations to force out bad actors marketing illegal and counterfeit products.”
In the majority opinion, the Court stated that FDA needed to consider relevant marketing strategies and plans surrounding access and restrictions around minors included in the PMTAs, and not simply disregard those plans as historically insufficient. “The FDA offers its experience as its primary excuse for its refusal to consider the marketing and sales-access-restriction plans,” the Court’s majority ruled. “Experience fails as a justification...”
The majority also noted that administrative “efficiency” – i.e., quickly reviewing the many PMTAs submitted to FDA – was not an “excuse,” saying, “by definition, the requirement that federal agencies consider all ‘relevant factors,’ prohibits agency shortcuts.”
While the majority focused on FDA’s failure to review Bidi’s marketing plans and sales and access restrictions, the majority further noted, with respect to Bidi Vapor’s applications, that FDA also failed to consider key evidence including, among other things, “product information, scientific safety testing, literature reviews, consumer insight surveys, and details about the company’s youth access prevention measures, distribution channels, and adult-focused marketing practices,” which “target only existing adult vapor product users, including current adult smokers,” as well as Bidi Vapor’s state-of-the-art anti-counterfeit authentication system and retailer monitoring program.
At the time of this press release, FDA has not announced its plans moving forward. The agency could appeal the ruling or put Bidi Vapor’s PMTAs for its non-tobacco flavored devices into scientific review. The Court ruling “remands”, or sends, the applications back to the FDA for action. The dissenting judge sided with FDA and its arguments that it has not seen any marketing or access plans that would reduce youth access, or that non-tobacco flavored vaping products offer an advantage over tobacco-flavored vaping products in decreasing smoking among existing smokers, despite the fact that FDA admittedly did not even review Bidi Vapor’s submitted marketing plan or other evidence.
“We believe that Bidi Vapor has provided FDA with substantial, robust and reliable scientific evidence through, among other things, surveys, behavioral studies and clinical trials on our BIDI® Stick products. We are confident the science will prove that the BIDI® Stick is appropriate for public health (APPH),” noted Kaival Brands Chief Science Officer and Founder, Niraj Patel. “Following on FDA’s initial administrative stay of the MDO, we believed that the subsequent judicial stay was a good indication that the Court found some merit in Bidi Vapor’s arguments and puts Bidi Vapor's PMTAs for the non-tobacco flavored ENDS one step closer to being properly and fully evaluated by the FDA. Bidi Vapor’s victory in our merits case confirms our prior beliefs. We look forward to cooperating with the agency through the scientific review process.”
Leading with Integrity
Bidi Vapor submitted PMTAs for all 11 flavor varieties (nine flavored ENDS plus menthol and tobacco) of its BIDI® Stick prior to the court-ordered September 9, 2020 PMTA deadline. The detailed applications ran over 285,000 pages and contained significant information supporting the products as appropriate for the protection of the public health – including robust and reliable scientific data supporting that its non-tobacco flavored BIDI® Sticks provide an added benefit to adult smokers over tobacco-flavored ENDS.
Despite submitting scientifically rigorous PMTAs and keeping FDA informed about its ongoing clinical and behavioral studies, among other things, Bidi Vapor received an MDO for its non-tobacco flavored BIDI® Sticks, along with nearly all other manufacturers of such flavored ENDS, in early September 2021. On September 29, 2021, Bidi Vapor filed a Petition for Review of the MDO with the 11th Circuit. That MDO was initially administratively stayed by FDA; after that administrative stay was lifted in December 2021, the 11th Circuit stayed the MDO on February 1, 2022. Oral arguments were heard on May 17, 2022 in Miami, Florida.
On August 23, 2022, the 11th Circuit ruled on the Petition for Review in favor of Bidi Vapor. This ruling effectively reverses the MDO and allows Bidi Vapor to continue to market all flavor varieties of the BIDI® Stick in the United States. All ENDS product on the market today that do not have marketing authorization from FDA are subject to enforcement, at the Agency’s discretion.
Since its MDO was issued, Bidi Vapor has continued to supplement its comprehensive PMTAs with additional science, including clinical and behavioral studies supporting that its products are APPH, which Bidi Vapor believes FDA must now also consider on remand as part of a full scientific review of its applications.
ABOUT BIDI VAPOR
Based in Melbourne, Florida, Bidi Vapor maintains a commitment to responsible adult-focused marketing, strict youth access prevention measures and age-verification standards, as well as sustainability through its BIDI® Cares recycling program. Bidi Vapor’s device, the BIDI® Stick, is a premium product made with high-quality components, a UL-certified battery and technology designed to deliver a consistent vaping experience for adult smokers 21 and over. Bidi Vapor is also adamant about strict compliance with all federal, state, and local guidelines and regulations. At Bidi Vapor, innovation is key to its mission, with the BIDI® Stick
Mansax… I think you’re spot on. The Philip Morris connection is going to open doors and windows that can’t help but increase the bottom line!
I spect anticipation of the next quarterly report will bring out some higher highs.
Plus, if the FDA green light turns on, I think all bets are off. Share price will precede revenue and profits because then it will just be a matter of time!
Would like to see the agreement terms.
This chain is clearly broken.................for now
Clearly another link in the chain!
Selling has the same effect regardless of why the selling is occurring. The ceo put out notice a while back that he is selling. My guess is it is part of the deal with PM. They don't want him to have so many shares when they can let their insiders buy them.
Followers
|
175
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
16002
|
Created
|
04/09/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |